Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UCB Farchim SA

www.ucb-group.com

Latest From UCB Farchim SA

The Quality Lowdown: More Concerns Raised About API Plants, Data Integrity And Sterility Assurance

Recent enforcement activities shed light on compliance challenges at ALI, UCB, Novo, Samsung, Nectar, Panacea and Beximco.

Quality Compliance

China Suspends GSK Tender Qualification Under Dutasteride Ban

GSK becomes the second foreign pharma firm in recent months to be hit with a ban on the import, sale and use of a product by increasingly assertive Chinese regulatory authorities.

China Market Access

China Suspends GSK Tender Qualification Under Dutasteride Ban

GSK becomes the second foreign pharma firm in recent months to be hit with a ban on the import, sale and use of a product by increasingly assertive Chinese regulatory authorities.

China Policy
See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register